Study suggests glucagon-like peptide-1 receptor agonists related to adolescent weight loss
Preliminary evidence from a clinical trial suggests that treatment with glucagon-like peptide-1 (GLP-1) receptor agonists was associated with reduced body mass index and body weight in adolescents with severe obesity, according ...
Feb 4, 2013
0
0